Geodon en es it fr

Geodon Brand names, Geodon Analogs

Geodon Brand Names Mixture

  • No information avaliable

Geodon Chemical_Formula


Geodon RX_link

Geodon fda sheet

Geodon FDA

Geodon msds (material safety sheet)

Geodon MSDS

Geodon Synthesis Reference

J. A. Lowe III, A. A. Nagel, Eur. pat. Appl. 281,309; eidem, U.S. pat. 4,831,031 (1988, 1989 both to Pfizer).

Geodon Molecular Weight

412.936 g/mol

Geodon Melting Point

>300 oC

Geodon H2O Solubility

No information avaliable

Geodon State


Geodon LogP


Geodon Dosage Forms

Capsule; Injection;

Geodon Indication

For the treatment of schizophrenia

Geodon Pharmacology

Ziprasidone is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. Ziprasidone is a selective monoaminergic antagonist with high affinity for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), 1 and 2 adrenergic, and H1 histaminergic receptors. Ziprasidone acts as an antagonist at other receptors, but with lower potency. Antagonism at receptors other than dopamine and 5HT2 with similar receptor affinities may explain some of the other therapeutic and side effects of Ziprasidone. Ziprasidone's antagonism of muscarinic M1-5 receptors may explain its anticholinergic effects. Ziprasidone's antagonism of histamine H1 receptors may explain the somnolence observed with this drug. Ziprasidone's antagonism of adrenergic a1 receptors may explain the orthostatic hypotension observed with this drug. Ziprasidone functions as an antagonist at the Dopamine D2 , 5HT-2A , and 5HT-1D receptors, and as an agonist at the 5HT-1A receptor. Ziprasidone also inhibits synaptic reuptake of serotonin and norepinephrine.

Geodon Absorption


Geodon side effects and Toxicity

No information avaliable

Geodon Patient Information

Geodon Organisms Affected

Humans and other mammals